These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23446043)

  • 1. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing.
    Longati P; Jia X; Eimer J; Wagman A; Witt MR; Rehnmark S; Verbeke C; Toftgård R; Löhr M; Heuchel RL
    BMC Cancer; 2013 Feb; 13():95. PubMed ID: 23446043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma: Characterization in a 3D-cell culture model.
    Gagliano N; Celesti G; Tacchini L; Pluchino S; Sforza C; Rasile M; Valerio V; Laghi L; Conte V; Procacci P
    World J Gastroenterol; 2016 May; 22(18):4466-83. PubMed ID: 27182158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
    Hwang HJ; Oh MS; Lee DW; Kuh HJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles.
    Tidwell TR; Røsland G; Tronstad KJ; Søreide K; Hagland HR
    Cancer Med; 2024 Jun; 13(11):e7318. PubMed ID: 38872378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
    Wong CW; Han HW; Tien YW; Hsu SH
    Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.
    Monteiro MV; Gaspar VM; Mendes L; Duarte IF; Mano JF
    Small Methods; 2021 May; 5(5):e2001207. PubMed ID: 34928079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
    Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
    Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-spheroids: What can they tell us about pancreatic ductal adenocarcinoma cell phenotype?
    Gagliano N; Sforza C; Sommariva M; Menon A; Conte V; Sartori P; Procacci P
    Exp Cell Res; 2017 Aug; 357(2):299-309. PubMed ID: 28571915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonic cavitation induces necrosis and impairs growth in three-dimensional models of pancreatic ductal adenocarcinoma.
    Abou Ali E; Bordacahar B; Mestas JL; Batteux F; Lafon C; Camus M; Prat F
    PLoS One; 2018; 13(12):e0209094. PubMed ID: 30596678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system.
    Schuth S; Le Blanc S; Krieger TG; Jabs J; Schenk M; Giese NA; Büchler MW; Eils R; Conrad C; Strobel O
    J Exp Clin Cancer Res; 2022 Oct; 41(1):312. PubMed ID: 36273171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
    Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
    Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism.
    Ibello E; Saracino F; Delle Cave D; Buonaiuto S; Amoroso F; Andolfi G; Corona M; Guardiola O; Colonna V; Sainz B; Altucci L; De Cesare D; Cobellis G; Lonardo E; Patriarca EJ; D'Aniello C; Minchiotti G
    J Exp Clin Cancer Res; 2024 Jun; 43(1):165. PubMed ID: 38877560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an in vitro 3D PDAC stroma rich spheroid model.
    Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
    Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model.
    Yeon SE; No da Y; Lee SH; Nam SW; Oh IH; Lee J; Kuh HJ
    PLoS One; 2013; 8(9):e73345. PubMed ID: 24039920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
    Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
    J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and cytoskeletal changes of pancreatic cancer cells in three-dimensional spheroidal culture.
    Matsuda Y; Ishiwata T; Kawamoto Y; Kawahara K; Peng WX; Yamamoto T; Naito Z
    Med Mol Morphol; 2010 Dec; 43(4):211-7. PubMed ID: 21267697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids.
    LeSavage BL; Zhang D; Huerta-López C; Gilchrist AE; Krajina BA; Karlsson K; Smith AR; Karagyozova K; Klett KC; Huang MS; Long C; Kaber G; Madl CM; Bollyky PL; Curtis C; Kuo CJ; Heilshorn SC
    Nat Mater; 2024 Aug; 23(8):1138-1149. PubMed ID: 38965405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs.
    Brumskill S; Barrera LN; Calcraft P; Phillips C; Costello E
    J Physiol Biochem; 2023 Feb; 79(1):223-234. PubMed ID: 34865180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.